Answer
Aug 19, 2026 - 11:42 AM
CagriSema is a combination drug developed and manufactured by the pharmaceutical company Novo Nordisk. It combines cagrilintide and semaglutide for the treatment of obesity and type 2 diabetes.
Who is the manufacturer of CagriSema? CagriSema Medications
Status:
Open Aug 19, 2026 - 11:42 AM
Do you have the same question? Follow this Question
1answer
Browse by Category
Medications
View our complete selection of Medications to find the one that suites your needs.
View All
View all Medications Questions & Answers
View all CagriSema Questions & Answers
